
Markel Group Inc. (NYSE:MKL – Free Report) – Research analysts at Zacks Research lifted their Q4 2026 EPS estimates for Markel Group in a research note issued on Monday, December 22nd. Zacks Research analyst Team now anticipates that the insurance provider will post earnings of $29.87 per share for the quarter, up from their previous forecast of $29.51. Zacks Research has a “Strong-Buy” rating on the stock. The consensus estimate for Markel Group’s current full-year earnings is $96.25 per share.
Markel Group (NYSE:MKL – Get Free Report) last issued its earnings results on Wednesday, October 29th. The insurance provider reported $30.90 earnings per share for the quarter, beating analysts’ consensus estimates of $22.77 by $8.13. The firm had revenue of $3.93 billion for the quarter, compared to analyst estimates of $3.77 billion. Markel Group had a net margin of 12.99% and a return on equity of 7.76%.
Markel Group Stock Performance
Shares of Markel Group stock opened at $2,182.93 on Wednesday. The stock has a market cap of $27.53 billion, a price-to-earnings ratio of 13.67 and a beta of 0.81. Markel Group has a twelve month low of $1,621.89 and a twelve month high of $2,207.59. The company’s fifty day moving average is $2,040.93 and its 200 day moving average is $1,986.08. The company has a quick ratio of 0.60, a current ratio of 0.60 and a debt-to-equity ratio of 0.24.
Insider Buying and Selling
In other Markel Group news, CEO Simon Wilson sold 75 shares of Markel Group stock in a transaction that occurred on Tuesday, November 25th. The shares were sold at an average price of $2,072.94, for a total transaction of $155,470.50. Following the transaction, the chief executive officer owned 1,770 shares of the company’s stock, valued at $3,669,103.80. This trade represents a 4.07% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Steven A. Markel sold 1,330 shares of the business’s stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $2,119.12, for a total value of $2,818,429.60. Following the completion of the transaction, the director directly owned 60,368 shares in the company, valued at approximately $127,927,036.16. This represents a 2.16% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 1,575 shares of company stock worth $3,330,900 in the last 90 days. Corporate insiders own 1.66% of the company’s stock.
Institutional Trading of Markel Group
A number of large investors have recently bought and sold shares of the company. Allworth Financial LP lifted its stake in Markel Group by 60.8% in the 3rd quarter. Allworth Financial LP now owns 267 shares of the insurance provider’s stock worth $511,000 after purchasing an additional 101 shares in the last quarter. CIBC Private Wealth Group LLC grew its position in Markel Group by 10.8% during the third quarter. CIBC Private Wealth Group LLC now owns 277 shares of the insurance provider’s stock valued at $529,000 after acquiring an additional 27 shares during the last quarter. CIBC Bancorp USA Inc. purchased a new stake in shares of Markel Group in the 3rd quarter valued at $870,000. WBI Investments LLC bought a new position in shares of Markel Group during the third quarter valued at about $291,000. Finally, Sunbelt Securities Inc. grew its position in Markel Group by 672.6% during the 3rd quarter. Sunbelt Securities Inc. now owns 1,298 shares of the insurance provider’s stock worth $2,481,000 after acquiring an additional 1,130 shares during the last quarter. 77.12% of the stock is owned by hedge funds and other institutional investors.
Markel Group Company Profile
Markel Group (NYSE: MKL) is a diversified insurance holding company best known for underwriting specialty insurance products. Founded in 1930 and headquartered in Richmond, Virginia, the company provides a wide range of commercial property and casualty coverages tailored to niche and hard-to-place risks. Its underwriting operations focus on specialty lines across multiple industries, delivering customized policy structures, program administration, and claims management services for complex exposures.
In addition to primary specialty insurance, Markel operates reinsurance and alternative risk-transfer activities and manages invested assets derived from underwriting float.
Featured Stories
- Five stocks we like better than Markel Group
- Put $1,000 into this stock by Jan 1 [Not NVDA]
- Do you know what Amazon is planning for January 1?
- Turn your “dead money” into $306+ monthly (starting this month)
- Washington prepares for war
- Strange Crystal Metal Outperforms Silicon Up to 100X
Receive News & Ratings for Markel Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel Group and related companies with MarketBeat.com's FREE daily email newsletter.
